Celsion Corporation (NASDAQ:CLSN)

CAPS Rating: 1 out of 5

A biotechnology company dedicated to furthering the development and commercialization of treatment systems for cancer and other diseases using focused heat energy in combination with other therapeutic devices or heat-activated genes.


Player Avatar mdriver78 (62.47) Submitted: 4/28/2011 3:05:16 PM : Underperform Start Price: $14.22 CLSN Score: -0.49

Only $1.1 MM in cash, approved patents in US and Japan spells share offering on the horizon.

Featured Broker Partners